Enfusion, Inc. (NYSE:ENFN) Q4 2023 Earnings Conference Call March 12, 2024 8:30 AM ET
Company Participants
Bill Wright - Head, IR
Oleg Movchan - CEO
Brad Herring - CFO
Neal Pawar - COO
Conference Call Participants
Michael Infante - Morgan Stanley
Dylan Becker - William Blair
Alexei Gogolev - JPMorgan
Natalie Howard - Bank of America
Gabriela Borges - Goldman Sachs
Operator
Good morning, ladies and gentlemen. Thank you for standing by. Welcome to Enfusion's Fourth and Full Year 2023 Earnings Conference Call. [Operator Instructions] As a reminder, this conference call is being recorded.
I'd now like to turn the call over to Bill Wright, Head of Investor Relations, to begin.
Bill Wright
Good morning, and thank you, operator. We welcome you to Enfusion's Fourth Quarter and Full Year 2023 Earnings Conference Call. Hosting today's call are Oleg Movchan, Enfusion's Chief Executive Officer; Brad Herring, Enfusion's Chief Financial Officer and Neal Pawar, Enfusion’s newly appointed Chief Operating Officer.
Please note, our quarterly shareholder letter, which includes our quarterly financial results have all been posted through our Investor Relations website. I would like to remind you that today's call may contain forward-looking statements. These forward-looking statements are subject to numerous risks and uncertainties, including those set forth in our filings with the SEC which are available in the Investor Relations section on our website. Actual results may differ materially from any forward-looking statements we make today. These forward-looking statements speak only as of today, and the company does not assume any obligation or intent to update them following today's call except as required by law.
In addition, today's call may include non-GAAP measures. These measures should be considered as a supplement to and not a substitute for GAAP financial measures. Reconciliation to the nearest GAAP measure can be found in today's quarterly Shareholder Letter, which is available on the company's website.
With that, I'd like to turn the call over to Oleg to begin.
Oleg Movchan
Good morning and thank you for joining us today to discuss our results in the fourth quarter of 2023. I’m honored to be completing my first four year as Enfusion’s CEO and thrilled to welcome Neal Pawar our new Chief Operating Officer to the Enfusion team.
Neal joined us in November and brings a tremendous amount of operating experience along with breadth and depth of technology experience across the financial services industry. In just the past three months, Neal's presence and enormous enthusiasm has been felt across our entire organization. We're sure Neal will be instrumental in helping us scale up the business and expand our market footprint with global enterprise clients.